BAX and cancer: As observed in Table 2 and Table 3, GTs tend to reduce the ΔΨm of cancer cells concomitantly with an increase in the bcl-2-like protein 4 (BAX) and Bcl-2 homologous antagonist/killer (BAK) proteins, which are key molecular drivers of MOMP [156,157].